SB-202190 (SB202190, SB 202190) is a highly selective cell-permeable inhibitor of p38 MAPK, inhibiting p38α (IC50: 50 nM) and p38β (IC50: 100 nM). SB-202190 can induce apoptosis by activating the cpp32-like caspases pathway, with typical apoptotic features such as nuclear condensation or intranuclear chromosomal DNA fragmentation. Features Purity≥98% Standardized production, using factory mass production mode Specifications Cat.No. 53005ES08/53005ES10/53005ES25 Size 5 mg/10 mg/25 mg Synonym SB202190；SB 202190 Target p38α；p38β CAS No. 152121-30-7 Molecular formula C20H14FN3O Molecular weight 331.34 Appearance solid powder Purity ≥98% Solubility soluble in DMSO Structure Components Components No. Name 53005ES08 53005ES10 53005ES25 53005 SB-202190 5 mg 10 mg 25 mg Shipping and Storage The SB-202190 products should be stored at -15～-25℃ for 2 years. Avoid repeated freeze-thaw cycles. Documents: Safety Data Sheet 53005_MSDS_HB20250210 _EN.pdf Manuals 53005_Manual_HB20250210 _EN.pdf
